Noriyuki Sasaki

Dionex Corp. develops, manufactures, sells, and services chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures. The firm's products are used extensively by the environmental, life science, pharmaceutical, food and beverage, chemicals, electronics and power industries. The company was founded in 1975 and is headquartered in Sunnyvale, CA.

Nalge Nunc International Corp. Designs, develops, and manufactures plastic products. It designs, develops, and manufactures plastic products for use in laboratory, packaging, environmental, biotechnology, and life science applications. The company was founded in 1995 and is headquartered in Rochester, NY.

Remel, Inc. manufactures diagnostic products which are used in microbiology labs. Its products include prepared culture media, dehydrated culture media, collection and transport systems, diagnostic tests, quality control systems, laboratory supplies and susceptibility. The company was founded in 1973 and is headquartered Lenexa, KS.

Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA.

NovaWave Technologies, Inc. develops optically based chemical detection instrumentation. Its products include fiber laser products, such as EDFA/YDFA PM fiber laser modules for sensing applications that require a high degree of polarization purity, frequency stability, and low optical noise. The company was founded by Joshua B. Paulin 2002 and is headquartered in Waltham, MA.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT.

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001.

Life Technologies Clinical Services Lab, Inc. offers clinically guided personal genetic testing services for customers. The firm develops and commercializes genetics-based products and services to enhance individual health and wellness; and educates and empowers individuals and their physicians by providing personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by David B. Agus and Dietrich A. Stephan in 2006 and is headquartered in Foster City, CA.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

FEI Houston, Inc. provides 3 dimensional visualization toolkits and software for engineers and scientists. It develops development of professional applications in medical, engineering, oil and gas, and mining markets. The company was founded in 1986 and is headquartered in Houston, TX.

Medical Analysis Systems, Inc. provides blood derivative diagnostic agency services. The company is headquartered in Fremont, CA.

PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.

Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI.

Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO.

PHITONEX, Inc. engages in technological services. The company was founded in 2017 and is headquartered in Durham, NC.

Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA.

Leinco Technologies, Inc. is a specialty manufacturer of early discovery research products, including antibodies, recombinant proteins, ELISA kits, and other life sciences products. Leinco Technologies is based in St. Louis, MO, and operates out of a 27,000 square foot facility with significant laboratory space to service all customer and regulatory requirements. The company also offers a full suite of custom development and manufacturing services and serves leading drug discovery and in vitro diagnostic companies around the world. The company was founded in 1992 by Patrick Leinert, who has been the CEO since then.